Stocks · Healthcare · Medical - Healthcare Information Services
CareCloud, Inc. CCLD
$2.02 -0.98% Close, Oct 2, 2026 · NASDAQ · Market cap $85.8M
High qualityWeak trendInexpensive vs sector
Next earnings report: Nov 5, 2026
Scroll or pinch to zoom, drag to move. Daily prices adjusted for splits. Markers: E = earnings (green beat, red miss), S = split, D = dividend.
Three things to know
- The diluted share count rose 28.3% in a year.
- The stock is in a downtrend: below its 200-day average, with the 50-day average below the 200-day.
- Over the past year the stock returned -39.7%, behind the S&P 500 by 54.8 percentage points.
PromtFinance scores
Each score is a percentile within the Healthcare sector (0–100). Under each score: how the stock ranks in its sector on every component. As of Oct 5, 2026.
How fast revenue, earnings and cash flow are growing.
- Revenue growth (TTM, YoY)Top 40%
- FCF growth (TTM, YoY)Top 33%
- Revenue growth, 3-year CAGRBottom 16%
- Revenue growth accelerationTop 18%
Returns on capital, margins, earnings quality and balance-sheet strength.
- Return on invested capitalTop 9%
- Gross marginBottom 20%
- Operating marginTop 31%
- Cash conversion (OCF / net income)Top 10%
- Accruals (lower is better)Top 14%
- Net debt / EBITDA (lower is better)Bottom 47%
- Interest coverTop 16%
How cheap the shares are relative to earnings, cash flow and their own history.
- Earnings yieldTop 16%
- Free-cash-flow yieldTop 1%
- EBITDA / enterprise valueTop 3%
- Sales / enterprise valueTop 9%
- P/E vs own 5-year history (lower is better)Bottom 34%
Strength and persistence of the price trend, including versus the S&P 500.
- 12-month return excluding last monthBottom 15%
- 6-month returnBottom 9%
- 1-year return vs S&P 500Bottom 15%
- Distance from 52-week highBottom 31%
- Trend checklist (0–4)Bottom 14%
Earnings surprises and analyst sentiment (estimate-revision history is being collected).
- Average EPS surprise, last 4 quartersBottom 16%
- Consecutive EPS beatsBottom 49%
- Share of analysts rating BuyBottom 47%
- Upside to consensus price targetBottom 46%
Low volatility, shallow drawdowns, low market sensitivity and modest leverage.
- Volatility, 60 days (lower is better)Bottom 40%
- Maximum drawdown, 3 yearsBottom 43%
- Beta vs S&P 500 (lower is better)Bottom 28%
- Net debt / EBITDA (lower is better)Bottom 47%
What changed
Latest four quarters versus the same period a year earlier (growth: versus one quarter earlier).
| Measure | Before | Now | |
|---|---|---|---|
| Revenue growth (YoY) | 10.3% | 15.1% | ↑ |
| Gross margin | 46.0% | 31.7% | ↓ |
| Operating margin | 10.5% | 7.3% | ↓ |
| FCF margin | 17.5% | 21.4% | ↑ |
Fundamental momentum
| Measure | Now (TTM) | Year / quarter before | Sector rank | |
|---|---|---|---|---|
| Revenue growth (TTM, YoY) | 15.1% | 10.3% | ↑ | Top 40% |
| Gross margin | 31.7% | 46.0% | ↓ | Bottom 20% |
| Operating margin | 7.3% | 10.5% | ↓ | Top 31% |
| Net margin | 6.2% | 10.1% | ↓ | — |
| Free-cash-flow margin | 21.4% | 17.5% | ↑ | — |
| Return on invested capital | 14.5% | — | Top 9% | |
| Revenue growth, 3-year CAGR | -4.6% | — | Bottom 16% |
Quality of earnings and balance sheet
- Cash conversion (OCF / net income)Above 1× means profits are backed by cash.
- 3.00×
- Accruals (net income − OCF) / assetsLower is better; high accruals can signal weaker earnings quality.
- -20.0%
- Stock-based compensation / revenueA cost to shareholders through dilution.
- 0.1%
- Receivables growth vs revenue growthReceivables growing much faster than sales can be a warning.
- -14.9 pp
- Net debt / EBITDABelow 1× is conservative; above 3× is high leverage.
- 1.47×
- Interest cover (operating income / interest)How many times operating profit covers interest.
- 9.1×
Shareholder returns
- Dividend yield (dividends paid, TTM)
- 0.00%
- Net buyback yield (TTM)
- -0.03%
- Shareholder yield
- -0.03%
- Share count change, 1 year
- +28.3%
- Share count change, 3-year CAGR
- +39.6%
Shareholder yield = dividends + net buybacks over the last four quarters, divided by market cap.
Based on the four quarters through Jun 30, 2026 (filed Aug 6, 2026).
Earnings and expectations
Earnings momentum
- Consecutive EPS beats
- 1
- Beats in the last 8 reports
- 2 of 8
- Average EPS surprise, last 4
- -39.7%
- Average 2-day reaction, last 8
- +5.6%
- Positive 20 days after report
- 5 of 8
Analysts
- Consensus price target
- $3.13
- Target vs current price
- +55.0%
- Analysts with a rating
- 8
- Share rating Buy or Strong Buy
- 75%
- Consensus rating
- Buy
How the stock reacted to recent reports
| Report date | EPS surprise | 2 days | 5 days | 20 days | 60 days |
|---|---|---|---|---|---|
| Aug 6, 2026 | +71.5% | -8.7% | -3.5% | -11.8% | — |
| May 7, 2026 | -116.7% | -17.4% | -29.1% | -19.7% | -11.4% |
| Mar 12, 2026 | -63.6% | +9.4% | +34.2% | +3.8% | -11.7% |
| Nov 6, 2025 | -50.0% | +17.6% | +8.8% | +6.4% | -14.2% |
| Aug 5, 2025 | -12.5% | +0.0% | +7.6% | +54.6% | +27.7% |
| May 6, 2025 | -157.1% | +22.3% | +16.0% | +24.0% | +36.0% |
| Mar 13, 2025 | -99.3% | +0.0% | +3.1% | -13.8% | +36.3% |
| Nov 12, 2024 | +70.7% | +21.5% | +6.9% | +70.9% | +76.6% |
Returns from the close before each report. Past reactions do not determine future ones.
Earnings history
| Report date | EPS | Estimate | Surprise | Revenue |
|---|---|---|---|---|
| Aug 6, 2026 | $0.04 | $0.02 | +71.5% | $31.9M |
| May 7, 2026 | -$0.01 | $0.06 | -116.7% | $31.3M |
| Mar 12, 2026 | $0.04 | $0.11 | -63.6% | $34.4M |
| Nov 6, 2025 | $0.04 | $0.08 | -50.0% | $31.1M |
| Aug 5, 2025 | $0.07 | $0.08 | -12.5% | $27.4M |
| May 6, 2025 | -$0.04 | $0.07 | -157.1% | $27.6M |
| Mar 13, 2025 | $0.00 | $0.09 | -99.3% | $28.2M |
| Nov 12, 2024 | -$0.04 | -$0.14 | +70.7% | $28.5M |
Valuation in context
| Multiple | Now | 5-year median | 5-year percentile | Sector rank (cheapness) |
|---|---|---|---|---|
| P/E (trailing) | 28.9× | 18.2× | 60th | Top 16% |
| P/E (forward) | 7.3× | — | — | — |
| EV / EBITDA | 4.6× | — | — | Top 3% |
| EV / Sales | 0.98× | — | — | Top 9% |
| Free-cash-flow yield | 32.12% | — | — | Top 1% |
| Earnings yield | 3.46% | — | — | Top 16% |
P/E over the past five years
Range 5.8× – 85.5× since Dec 31, 2021. Each point: price on the filing date divided by trailing-twelve-month EPS known then.
Technical state
Trend checklist
- ✗ Price above 20-day average
- ✗ Price above 50-day average
- ✗ Price above 200-day average
- ✗ 50-day average above 200-day
- ✓ MACD histogram positive
Trend quality
- Days above the 50-day average
- 0
- Days above the 200-day average
- 0
- 50-day average slope (20 days)
- -2.3%
- 200-day average slope (20 days)
- -3.6%
- Distance from 50-day average
- -12.7%
- Distance from 200-day average
- -22.4%
- RSI (14)
- 37.4
- Relative volume
- 0.58×
Risk and drawdowns
- Volatility, 60 days (annualized)
- 60.9%
- Volatility vs own 5-year history
- 23th percentile · Normal for this stock
- Beta vs S&P 500 (2 years, weekly)
- 1.62
- Correlation with S&P 500
- 0.30
- Current drawdown from 1-year high
- -47.0%
- Maximum drawdown, 3 years
- -74.2%
Largest declines in the past six years
| From peak | To low | Decline | Length | Recovery |
|---|---|---|---|---|
| Feb 9, 2021 | Dec 14, 2023 | -93.8% | 717 days | Not yet recovered |
| Dec 7, 2020 | Dec 31, 2020 | -19.2% | 17 days | 18 days (Jan 28, 2021) |
| Oct 13, 2020 | Nov 2, 2020 | -16.4% | 14 days | 6 days (Nov 10, 2020) |
| Nov 10, 2020 | Nov 17, 2020 | -11.5% | 5 days | 2 days (Nov 19, 2020) |
| Jan 28, 2021 | Feb 4, 2021 | -10.5% | 5 days | 3 days (Feb 9, 2021) |
Declines of 10% or more from a closing high, measured on daily closes.
Financial statements
- Market cap
- $85.8M
- P/E (TTM)
- 28.9
- EPS, diluted (TTM)
- $0.07
- Revenue (TTM)
- $128.6M
- 52-week range
- $1.99 – $3.85
| FY 2021 | FY 2022 | FY 2023 | FY 2024 | FY 2025 | |
|---|---|---|---|---|---|
| Revenue | $139.6M | $138.8M | $117.1M | $110.8M | $120.5M |
| Gross profit | $52.7M | $54.4M | $46.2M | $50.0M | $56.0M |
| Operating income | $3.5M | $6.6M | -$47.1M | $9.1M | $11.5M |
| Net income | $2.8M | $5.4M | -$48.7M | $7.9M | $10.8M |
| EPS (diluted) | -$0.77 | -$0.67 | -$4.11 | -$0.28 | $0.09 |
| Q3 2024 | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 | Q4 2025 | Q1 2026 | Q2 2026 | |
|---|---|---|---|---|---|---|---|---|
| Revenue | $28.5M | $28.2M | $27.6M | $27.4M | $31.1M | $34.4M | $31.3M | $31.9M |
| Net income | $3.1M | $3.3M | $1.9M | $2.9M | $3.1M | $2.9M | $922,000 | $1.1M |
| EPS (diluted) | -$0.04 | $0.00 | -$0.04 | $0.04 | $0.04 | $0.04 | -$0.01 | $0.00 |
| FY 2021 | FY 2022 | FY 2023 | FY 2024 | FY 2025 | |
|---|---|---|---|---|---|
| Operating cash flow | $13.3M | $21.2M | $15.5M | $20.6M | $28.6M |
| Capital expenditure | -$10.6M | -$11.8M | -$11.6M | -$1.7M | -$8.0M |
| Free cash flow | $2.8M | $9.4M | $3.8M | $18.9M | $20.5M |
| Dividends paid | $0 | $0 | $0 | $0 | -$6.3M |
| Net share buybacks | $9.2M | -$20.0M | $1.4M | -$579,000 | -$24,000 |
Cash outflows are shown as negative numbers.
- Cash and short-term investments
- $13.4M
- Total assets
- $93.8M
- Total liabilities
- $76.4M
- Total debt
- $54.0M
- Net debt
- $40.6M
- Shareholders’ equity
- $17.4M
As of Jun 30, 2026 (filed Aug 6, 2026).
Short interest
- Shares sold short
- 604,207
- Days to cover
- 2.19
- Change vs previous report
- +11.9%
FINRA short interest, settlement date Sep 15, 2026.